Pelvic relapses in ovarian cancer. Role of CA-125, transvaginal ultrasound and color Doppler

European Journal of Gynaecological Oncology

Volumn 24, Issue 3-4, 2003, Pages 269-270

  Caserta, D ^a   Marci, R ^a,b   Porzio, G ^a   Di Roma, E ^a   Moscarini, M ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Ca 125; Ovarian Cancer; Pelvic relapse; Transvaginal ultrasound

Indexed keywords

PLATINUM DERIVATIVE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; NEOVASCULARIZATION (PATHOLOGY); OVARY CANCER; RADIOIMMUNOASSAY; TRANSVAGINAL ECHOGRAPHY;

AGED; CA-125 ANTIGEN; CARCINOMA; COHORT STUDIES; COMBINED MODALITY THERAPY; ENDOSONOGRAPHY; FEMALE; HUMANS; ITALY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; PROGNOSIS; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0037676140     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Porsbjerg C.M., Sorensen J.B.: "The role of tumor marker CA-125 in the treatment of ovarian cancer". Ugeskr. Laeger., 1998, 160 (7), 995.
2. Gard G.B., Houghton R.S.: "An assessment of the value serum CA-125 measurements in the management of epithelial ovarian carcinoma". Gynecol. Oncol., 1994, 53 (2), 83.
3. Van der Burg M.E.: "The role of CA-125 in the earlier diagnosis of progressive disease in ovarian cancer". Ann. Oncol., 1990, 1, 301.
4. Oehler M.K., Sutterlin M., Caffier H.: "CASA and CA-125 in diagnosis and follow-up of advanced ovarian cancer". Anticancer Res., 1999, 19 (suppl.), 2513.
5. Wagner U., Kohler S.: "Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA 125: immune response and survival in palliative treatment". Clin. Cancer Res., 2001, 7 (5), 1154.
6. Konecny G., Untch M.: "Association of Urokinase - type plasminogenactivator and its inhibitor with disease progression and prognosis in ovarian cancer". Clin. Cancer Res., 2001, 7 (6), 1743.
7. Guerriero S., Ajossa S., Risalvato A., Lai M.P., Mais V., Angiolucci M., Melis G.B.: "Diagnosis of adnexal malignancies by using color Doppler energy imaging as a secondary test in persistent masses". Ultrasound Obstet. Gynecol., 1998, 4, 277.
8. Alcazar J.L., Errasti T., Zornoza A., Minguez J.A., Galan M.J.: "Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses". Int. J. Gynecol. Obstet., 1999, 66 (3), 255.
9. Schneider V.L., Reed A.K.L, Hatch K.D.: "Comparison of Doppler with two dimensional sonography and CA-125 for prediction of malignancy of pelvic masses". Obstet. Gynecol., 1993 (81), 983.
10. Bromely, Goodman H., Benacerraf B.R.: "Comparison between sonographic morphology and Doppler waveform for the diagnosis of ovarian malignancy". Obstet. Gynecol., 1994 (83), 434.
11. Laframboise S., Nedelw R.: "Use of CA-125 and ultrasound in high risk women". Int. J. Gynecol. Cancer, 2002, 12 (1), 86.
12. Wan X., Suy: "Color Doppler ultrasound and quantitative histologic study of angiogenesis in ovarian tumor". Zhonghua Yi Xue Za Zhi, 2000, 80 (9), 672.
13. Allen D.J., Baak J., Belpomme D., Berek J.S., Bertelse K., Ten Bokkel H. et al.: "Advanced epithelial ovarian cancer, 1993 consensus Statements". Ann. Oncol., 1993 (suppl.), 4, 83.
14. Folkman J., Ingber D.: "Inhibition of angiogenesis". Semin. Cancer Biol., 1992 (3), 89.
15. Folkman J.: "Angiogenesis research: from laboratory to clinic". Forum (Genova) 1999, 9 (suppl.) 3, 59.
16. Maggino T., Gadducci A.: "Serum markers as prognostic factor in epithelial ovarian cancer: an overview". Eur. J. Gynaecol. Oncol., 2000, 21 (1), 64.
17. Magiani F., Fazio F.: "Diagnosis of persistent ovarian carcinoma with three step immunoscintigraphy". Br. J. Cancer, 2000, 82 (3), 616.
18. Markmann M.: "Resetting CA-125 range for a complete response to chemotherapy, why?". Gynecol. Oncol., 1994 (53), 281.